Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

The RNA component of human telomerase.

Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, et al.

Science. 1995 Sep 1;269(5228):1236-41.

PMID:
7544491
2.

Functional characterization and developmental regulation of mouse telomerase RNA.

Blasco MA, Funk W, Villeponteau B, Greider CW.

Science. 1995 Sep 1;269(5228):1267-70.

PMID:
7544492
3.

Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT.

Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, Holt SE, Bodnar AG, Lichtsteiner S, Kim NW, Trager JB, Taylor RD, Carlos R, Andrews WH, Wright WE, Shay JW, Harley CB, Morin GB.

Nat Genet. 1997 Dec;17(4):498-502.

PMID:
9398860
4.
5.

Functional reconstitution of wild-type and mutant Tetrahymena telomerase.

Autexier C, Greider CW.

Genes Dev. 1994 Mar 1;8(5):563-75.

6.

Inhibition of human telomerase by a retrovirus expressing telomeric antisense RNA.

Bisoffi M, Chakerian AE, Fore ML, Bryant JE, Hernandez JP, Moyzis RK, Griffith JK.

Eur J Cancer. 1998 Jul;34(8):1242-9.

PMID:
9849487
7.

2-5A antisense therapy directed against human telomerase RNA inhibits telomerase activity and induces apoptosis without telomere impairment in cervical cancer cells.

Yatabe N, Kyo S, Kondo S, Kanaya T, Wang Z, Maida Y, Takakura M, Nakamura M, Tanaka M, Inoue M.

Cancer Gene Ther. 2002 Jul;9(7):624-30.

8.

Effect of antisense human telomerase RNA on malignant phenotypes of gastric carcinoma.

Yang SM, Fang DC, Yang JL, Liang GP, Lu R, Luo YH, Liu WW.

J Gastroenterol Hepatol. 2002 Nov;17(11):1144-52.

PMID:
12453272
9.

Telomerase activity in small-cell and non-small-cell lung cancers.

Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF, Piatyszek MA, Shay JW.

J Natl Cancer Inst. 1995 Jun 21;87(12):895-902.

PMID:
7666478
10.

The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit.

Bryan TM, Marusic L, Bacchetti S, Namba M, Reddel RR.

Hum Mol Genet. 1997 Jun;6(6):921-6.

PMID:
9175740
11.

Developmentally programmed healing of chromosomes by telomerase in Tetrahymena.

Yu GL, Blackburn EH.

Cell. 1991 Nov 15;67(4):823-32.

PMID:
1934071
12.
13.
14.

Specific association of human telomerase activity with immortal cells and cancer.

Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW.

Science. 1994 Dec 23;266(5193):2011-5.

PMID:
7605428
15.

Changes in telomerase activity and telomere length during human T lymphocyte senescence.

Pan C, Xue BH, Ellis TM, Peace DJ, Díaz MO.

Exp Cell Res. 1997 Mar 15;231(2):346-53.

PMID:
9087176
16.

Growth defects in mouse telomerase RNA-deficient cells expressing a template-mutated mouse telomerase RNA.

Marie-Egyptienne DT, Brault ME, Nimmo GA, Londoño-Vallejo JA, Autexier C.

Cancer Lett. 2009 Mar 18;275(2):266-76. doi: 10.1016/j.canlet.2008.10.027. Epub 2008 Dec 3.

PMID:
19056167
17.

Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity.

Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S.

EMBO J. 1992 May;11(5):1921-9.

18.

A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis.

Greider CW, Blackburn EH.

Nature. 1989 Jan 26;337(6205):331-7.

PMID:
2463488
19.

TLC1: template RNA component of Saccharomyces cerevisiae telomerase.

Singer MS, Gottschling DE.

Science. 1994 Oct 21;266(5184):404-9.

PMID:
7545955
20.

Allosteric inhibitors of telomerase: oligonucleotide N3'-->P5' phosphoramidates.

Pruzan R, Pongracz K, Gietzen K, Wallweber G, Gryaznov S.

Nucleic Acids Res. 2002 Jan 15;30(2):559-68.

Supplemental Content

Support Center